Ogbureke Kalu U E, Ogbureke Ezinne I
Department of Oral Biology, School of Dentistry, Medical College of Georgia, Augusta Georgia, U.S.A.
Open Dent J. 2010 Oct 21;4:201-6. doi: 10.2174/1874210601004010201.
Noma is a serious orofacial gangrene originating intraorally in the gingival-oral mucosa complex before spreading extraorally to produce a visibly destructive ulcer. Although cases of noma are now rarely reported in the developed countries, it is still prevalent among children in third world countries, notably in sub-Sahara Africa, where poverty, ignorance, malnutrition, and preventable childhood infections are still common. This review summarizes historical, epidemiological, management, and research updates on noma with suggestions for its prevention and ultimate global eradication. The global annual incidence remains high at about 140,000 cases, with a mortality rate exceeding 90% for untreated diseases. Where the patients survive, noma defects result in unsightly facial disfigurement, intense scarring, trismus, oral incompetence, and social alienation. Although the etiology has long been held to be infectious, a definitive causal role between microorganisms cited, and noma has been difficult to establish. The management of noma with active disease requires antibiotics followed by reconstructive surgery. Current research efforts are focused towards a comprehensive understanding of the epidemiology, and further elucidation of the microbiology and pathogenesis of noma.Although a formidable public health challenge, noma can be prevented with a potential for subsequent global eradication. To achieve both desirable goals, detection of early disease is crucial because these early lesions respond to conventional antibiotic treatments when instituted side by side with nutritional rehabilitation, and obviates the necessity for extensive surgical reconstruction often indicated in late stage disease. The eradication of noma in the developed world in the mid 20(th) century bears out the notion of a similar outcome following effective preventive strategies in Africa. A fundamental and necessary step towards attaining this goal is for the international community to adopt a perception of noma as an urgent global public health challenge. Research effort toward deciphering the microbiology, molecular events, and pathogenesis of noma also should intensify.
坏疽性口炎是一种严重的口腔面部坏疽,始于口腔内牙龈 - 口腔黏膜复合体,随后向口腔外扩散,形成明显的溃疡性破坏。尽管坏疽性口炎在发达国家现已很少见,但在第三世界国家的儿童中仍然普遍存在,尤其是在撒哈拉以南非洲地区,那里贫困、无知、营养不良和可预防的儿童感染仍然很常见。这篇综述总结了坏疽性口炎的历史、流行病学、治疗和研究进展,并提出了预防及最终在全球根除该病的建议。全球年发病率仍高达约14万例,未经治疗的疾病死亡率超过90%。患者存活下来后,坏疽性口炎造成的缺损会导致面部丑陋变形、严重瘢痕形成、牙关紧闭、口腔功能障碍和社会疏离。尽管长期以来认为其病因具有传染性,但所提及的微生物与坏疽性口炎之间的确切因果关系一直难以确定。对患有活动性疾病的坏疽性口炎患者的治疗需要使用抗生素,随后进行重建手术。目前的研究工作集中在全面了解流行病学,以及进一步阐明坏疽性口炎的微生物学和发病机制。尽管坏疽性口炎是一项艰巨的公共卫生挑战,但它是可以预防的,而且有可能随后在全球根除。为实现这两个理想目标,早期疾病的检测至关重要,因为这些早期病变在进行营养康复治疗的同时接受传统抗生素治疗会有反应,而且避免了晚期疾病通常需要的广泛手术重建的必要性。20世纪中叶发达国家坏疽性口炎的根除证明了在非洲采取有效预防策略后会有类似结果的观点。实现这一目标的一个基本且必要的步骤是国际社会将坏疽性口炎视为一项紧迫的全球公共卫生挑战。对坏疽性口炎的微生物学、分子事件和发病机制进行研究的力度也应加大。